Resources Contact Us Home
Matrix protein compositions for guided connective tissue growth

Image Number 4 for United States Patent #7033611.

The present invention relates to the use of enamel matrix, enamel matrix derivatives and/or enamel matrix proteins as therapeutic and/or cosmetic agents. These substances are used for the manufacture of a pharmaceutical and/or cosmetic composition for actively inducing, guiding and/or stimulating connective tissue growth and thus to prevent connective tissue scarring and/or contraction in a wound cavity and/or tissue defect that is characterized by a substantial loss of tissue. The invention comprises, in particular, the use of active enamel substances for guided connective soft tissue growth and resistance to contraction in deep cavity shaped wounds following loss or removal of significant volumes of tissue, such as e.g., after surgical removal of a tumor and especially in combination with radiation therapy.

  Recently Added Patents
Therapeutic rinse in a self-heating package
Medicament container
Push mechanism for efficiently sending aggregated data items to client
Driving system of display panel having a circuit of a voltage generator and driving method thereof
Method of isolating human neuroepithelial precursor cells from human fetal tissue
Probiotic Bifidobacterium strains
Hydrating lounge chair
  Randomly Featured Patents
Ensuring coherence between graphics and display domains
Nanowire crossbar implementations of logic gates using configurable, tunneling resistor junctions
Alcohol soluble benzazole polymers
Shredder with oiling mechanism
Surface light source device and backlight unit having the same
Electrosynthesis of sodium dithionite
Control for controller-assisted, manually shifted, synchronized, splitter type compound transmissions
Detection of epidemic outbreaks with Persistent Causal-Chain Dynamic Bayesian Networks
Packing structure for fluid containing column and manufacturing method
Package and support structure for radiation detector